Appendix 13 : ADS Diabetes Needs Assessment

Responses: 260

Other

• better access - diabetes clinic
• cholesterol targets and DM
• chronic renal disease
• comparison of oral agents
• control targets as applies to DM
• diabetes and pregnancy
• diet and exercise
• drugs in Parkinson's
• evidence-based strategies for management of laws
• evidence for non-medicine management
• evidence of NNT versus NNHI in relation to tight control
• exercise and nutrition
• exercise for diabetics
• frequency of foot checks
• glucose and other targets based on age and risk
• GTT and diabetes
• h.b.a.c
• Ifg and glucose intolerance, cholesterol and bp target
• Ifpg and Igt management/evidence
• insulin alone in DDM
• lifestyle changes
• lipid control
• management and treatment guidelines for screening
• management of acute coronary syndrome
• management of IPG/IGT
• monitoring
• more on insulin therapy
• newer drugs in treatment of diabetes
• of insulin delivery devices and relative ease of use
• pediatric diabetes
• patient education
• renal factions and diabetes
• review all drug treatments and combination of medications
• role of men with IKG/IGT
• sliding scale
• the incompliant diabetic patient
• use of ace/insulin, asa
• weight loss
• weight loss

Other

• "at risk" 5-8-6.0 management
• ACASA 81 mg
• ACE-1/ARB - do they protect the kidney?
• availability of publications with all aspects
• combination - maximum dosage/adjusting dosage
• compliance
• diet/exercise
• evidence related to outcome of NIDDM
• exercise
• insulin pumps
• insulin pump use and adjustment of pulse therapy
• insulin therapy and sliding scale
• microalbuminemia
• of F.D on management of diabetic nephropathy
• pre-diabetes versus diabetes and impact on targets
• starting insulin

Comments

• More information about insulin syringes.
• Role of metformin in prevention of DM, if there is positive family history or other risk factors like obesity.
• I would also like academic detailing on the use of Palm in family practice. Is this possible, now or in the future?
• Introduction of insulin for type II diabetics, (on max. oral meds)
• Changing from lente to other insulins.
• I am well informed on Type II, diabetes, BP targets, glucose targets, use, combined therapies.
• DEC's and patient education have generally improved the control that Type II diabetics have. I would be interested in material on what we should expect from DEC's, how they function, how often should patients be seen there, what they expect from us, and what we should expect from them.
• In terms of item 3, I would like the newer agents compared with metformin. Would like to know about UKPDS results in contrast with 2003 suggested treatment. Would also like to have level of evidence for the recommendations.
• RE: #1, Hba1c more important than "spot checks" for patients who are clinically stable. However, home glucose monitoring may enhance patient acceptance of disease and disease management.
• I would not participate as I have attended several courses on this in the past year.
• RE #3, latest study on giltazones does not show benefit for vascular complications.
• I would be interested in learning more about #3 and #5. The other topics are good but #1, #2 and #6 are preaching to the converted.
• Diet recommendations, mechanisms for diet referral/monitoring. "Prescriptions" for exercise - self regulated - gym.
• Some useful handouts on diet would be beneficial.
• Would be a very useful module.
• This is an excellent topic to cover. Looking forward it.
• Would like to be covered.
• I agree that it is important to divide the topic into bite-sized chunks.
• The most valuable legacy from such a session would be a handout or at least easy to understand statistics for the patient to see: getting BP/weight down will decrease my risk of MJ / stroke / amputation by (x)%.
• Would be beneficial in what is often a frustrating therapeutic undertaking.
• Very useful program.
• I would be happy to hear info on any of these topics in any order.
• Recently attended a 1-day CME put on by Dr. Adams and our excellent local DEC, so not interested.
• Other topics - female contraceptive options, drugs for treatment and prevention of diabetic neuropathy and the evidence to back this RE: ACE's and ARB's
• HBGM, BP targets well covered already
• Great topic. Especially since GP/FD's are going to have to initiate insulin more often for type II diabetes
• Type II diabetes is very common and we really need updates. The more we know and the more we want to know about diabetes.
• self help healing
• I'm aware of the evidence, just have difficulty getting patients to target i.e.: more help RE: how to use medications to reach targets
• Academic Detailing Service in office setup is very useful.
• Diabetes and DCB inhibitors in non-hypertensive patients
• 7. The mental/ behavioural and social issues
• 8. When to start the restriction of phosphorus and phoshate binders when the nephrologist has seen you patient more than once.
• 9. Importance of the multidisciplinary team in the community. How we can improve communication among health professionals, diabetic patients and their families.
• I look forward to your talks Isobel.
• 2:6 are well established but I would like to learn a bit more about the other topics.
• 7. is my number topic. Example: Diet, exercise, weight reduction
• Difficult to get proper training in the Academic Detailing. I am not interested in this type of education.